Non-Invasive Measurement of Central Blood Pressure (cBP)

This policy covers noninvasive estimation of central (proximal aortic) blood pressure and arterial stiffness (pulse wave velocity) using clinically validated, accurately calibrated arterial waveform devices (applanation tonometry or cuff‑based oscillometric systems such as SphygmoCor, PhysioWave, Arteriograph, Vicorder, Mobil‑O‑Graph) to generate central aortic pressure profiles for hypertension management and cardiovascular risk assessment. It is intended primarily for adults (≥18) and for uses such as risk stratification, assessing vascular disease severity, or tailoring antihypertensive therapy, but device- and technique-specific validation/calibration are required, evidence is insufficient to replace brachial cuff BP or demonstrate outcome benefit, many indications remain investigational/not covered, and coverage is subject to the member’s benefit plan.

"Non‑invasive measurement of central blood pressure (cBP) is considered experimental, investigational and/or unproven and is not covered."